Fresenius SE & Co. KGaA (FSNUY) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Care Facilities secteur d'activité. Le siège social de l'entreprise est situé à Bad Homburg vor der Höhe, Germany. Le PDG actuel est Michael Sen.
FSNUY a date d'introduction en bourse 2012-05-15, 175,202 employés à temps plein, cotée sur le Other OTC, une capitalisation boursière de $117.51B.
Fresenius SE & Co. KGaA is a diversified healthcare company headquartered in Germany that provides products and services across dialysis, hospital operations, and outpatient medical care. The company operates through four main divisions: Fresenius Medical Care, which specializes in dialysis products and services for chronic kidney failure patients; Fresenius Kabi, which offers intravenous drugs, nutritional products, biosimilars, and medical devices for therapeutic care; Fresenius Helios, which operates a large network of hospitals and outpatient clinics across Germany and Spain along with fertility treatment centers; and Fresenius Vamed, which provides project management, planning, construction, and operational services for healthcare facilities. Founded in 1912, the company has established itself as a global healthcare leader serving patients with serious illnesses across multiple continents.
